| Drossapharm AG - Rosuvastax-Drossapharm 5 mg, Filmtabletten | | 69613 | | 01 | | Rosuvastax-Drossapharm 5 mg | | Filmtabletten | | C10AA07 | | Rosuvastatin | | 03.04.2025 | | |
| | Composition | | Filmtablette: rosuvastatinum 5 mg ut rosuvastatinum calcicum 5.21 mg, cellulosum microcristallinum, lactosum monohydricum 48.98 mg, crospovidonum, hydroxypropylcellulosum, natrii hydrogenocarbonas corresp. natrium 0.07 mg, magnesii stearas, Überzug: lactosum monohydricum 1.10 mg, hypromellosum, E 171, triacetinum, E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. | informations additionels |
|---|
| Rosuvastatine | 5 mg | Filmtablette |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 171 | | color. | | E 172 | | color. | | Hydroxypropylcellulosum | | | | Hypromellosum | | | | Lactose Monohydrate | 1.1 mg | Überzug | | Magnesii Stearas | | | | Sodium Hydrogenocarbonate | | | | Pro Compresso Obducto | | | | Triacetinum | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 30 | DDP | DDP | B | | Non | | 002 | 100 | DDP | DDP | B | | Non |
|
|
